MB12066

DRUG2 trials

Sponsors

Yungjin Pharm. Co., Ltd.

Conditions

Metabolic SyndromeObesity

Phase 1

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

CompletedNCT01285388

Yungjin Pharm. Co., Ltd.Metabolic Syndrome, Obesity

Start: 2010-07-31End: 2011-01-31Updated: 2018-06-27

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

CompletedNCT01444677

Yungjin Pharm. Co., Ltd.Metabolic Syndrome, Obesity

Start: 2011-04-30End: 2012-04-30Target: 40Updated: 2017-12-21